Anadin analgesic tablets

Anadin is a long-standing brand of pain relief medication that first gained prominence in the United Kingdom during the early 20th century. Originally formulated as a combination of aspirin and caffeine, it became a staple in the British pharmaceutical market for treating headaches and minor pains. The brand's history is characterized by its evolution from a traditional remedy to a diverse range of pain management solutions including ibuprofen and paracetamol variants.

Over the decades, ownership of Anadin has shifted through significant corporate mergers and acquisitions. For a long period, it was a flagship brand of Wyeth, a major American pharmaceutical company. Following the acquisition of Wyeth by Pfizer in 2009, the brand became part of Pfizer's consumer healthcare portfolio. In 2019, a transformative joint venture between Pfizer and GlaxoSmithKline (GSK) combined their consumer health businesses, ultimately leading to the spin-off of this division as an independent entity.

Today, Anadin is owned and managed by Haleon, a world-leading consumer healthcare company headquartered in the United Kingdom. Haleon operates as an independent, publicly traded company after demerging from GSK in 2022. While the brand maintains a strong heritage in the UK and Ireland, its manufacturing is distributed across various global facilities specializing in over-the-counter pharmaceuticals to meet international safety and supply standards.